Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LumiMeds vs Options Medical Weight Loss

LumiMeds
Graded #143

Higher grade

vs+3.0999999999999943
Options Medical Weight Loss
Graded #218

Lower grade

The verdict

LumiMeds takes it — 68.6/100 to 65.5/100.

LumiMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth provider with flat-rate compounded GLP-1 pricing on a 3-month plan.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLumiMeds +23
77
54
Dose & formulationOptions Medical Weight Loss +13
64
77
Clinical oversightLumiMeds +1
82
81
Labs & monitoringEven
53
53
FulfillmentOptions Medical Weight Loss +2
65
67
Contract termsEven
55
55
LumiMeds · left barOptions Medical Weight Loss · right bar

The numbers

MetricLumiMedsOptions Medical Weight Loss
WeighScore68.6/10065.5/100
GradeCC
Scorecard rank#143#218
Semaglutide$133/mo (starting dose, compounded)$199/mo (compounded)
Tirzepatide$133/mo (starting dose, compounded)$399/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
LumiMeds

Graded #143 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Strengths

  • LegitScript certified with clear, upfront program pricing
  • Compounded semaglutide (~$239) and tirzepatide (from $299), plus NAD+
  • Structured metabolic-health program with provider support and accountability
  • HSA/FSA eligible with flexible payment options

Where it loses points

  • Doesn't clearly publish which states its telehealth covers
  • Tirzepatide tiers climb to $339-$399/month
  • More program structure (and cost) than medication-only sellers
  • Compounded GLP-1 only online — no brand-name options noted

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard